BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17159457)

  • 1. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.
    Endicott J; Rajagopalan K; Minkwitz M; Macfadden W;
    Int Clin Psychopharmacol; 2007 Jan; 22(1):29-37. PubMed ID: 17159457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
    J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
    Kim SJ; Lee YJ; Lee YJ; Cho SJ
    J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial.
    Pathak S; Findling RL; Earley WR; Acevedo LD; Stankowski J; Delbello MP
    J Clin Psychiatry; 2013 Jan; 74(1):e100-9. PubMed ID: 23419231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
    Findling RL; Pathak S; Earley WR; Liu S; DelBello MP
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):325-35. PubMed ID: 24956042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
    Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
    Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine: a review of its use in the treatment of bipolar depression.
    Keating GM; Robinson DM
    Drugs; 2007; 67(7):1077-95. PubMed ID: 17488148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues.
    Dawdy P
    J Clin Psychopharmacol; 2008 Jun; 28(3):367-8; author reply 368. PubMed ID: 18480707
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.
    Locklear JC; Svedsäter H; Datto C; Endicott J
    J Affect Disord; 2013 Jul; 149(1-3):189-95. PubMed ID: 23639212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.